Table of Contents
Journal of Angiology
Volume 2015, Article ID 205456, 9 pages
http://dx.doi.org/10.1155/2015/205456
Research Article

Heparin-Bonded Viabahn and Drug-Eluting Bare Metal Zilver (PTX) Sandwich Stents in Femoral Chronic Total Occlusion: A Retrospective Review of Mid-Term and Long-Term Outcomes

1Division of Radiological Sciences, School of Medicine, University of Nottingham, Queen’s Medical Centre, B Floor, West Block, Derby Road, Nottingham NG7 2UH, UK
2Department of Interventional Radiology, Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, B Floor, West Block, Derby Road, Nottingham NG7 2UH, UK

Received 28 September 2014; Accepted 19 December 2014

Academic Editor: Hironori Nakagami

Copyright © 2015 Amir Awwad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Norgren, W. R. Hiatt, J. A. Dormandy, M. R. Nehler, K. A. Harris, and F. G. R. Fowkes, “Inter-society consensus for the management of peripheral arterial disease (TASC II),” Journal of Vascular Surgery, vol. 45, no. 1, supplement, pp. S5–S67, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Kuhan, S. Abisi, B. D. Braithwaite, S. T. R. MacSweeney, S. C. Whitaker, and S. B. Habib, “Early results with the use of heparin-bonded stent graft to rescue failed angioplasty of chronic femoropopliteal occlusive lesions: TASC D lesions have a poor outcome,” CardioVascular and Interventional Radiology, vol. 35, no. 5, pp. 1023–1028, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. J. A. Dormandy and R. B. Rutherford, “Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC),” Journal of Vascular Surgery, vol. 31, no. 1, part 2, pp. S1–S296, 2000. View at Publisher · View at Google Scholar
  4. S. H. Duda, B. Pusich, G. Richter et al., “Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results,” Circulation, vol. 106, no. 12, pp. 1505–1509, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. J. R. Laird, B. T. Katzen, D. Scheinert et al., “Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial,” Circulation: Cardiovascular Interventions, vol. 3, no. 3, pp. 267–276, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Schillinger, S. Sabeti, C. Loewe et al., “Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery,” The New England Journal of Medicine, vol. 354, no. 18, pp. 1879–1888, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Schillinger, S. Sabeti, P. Dick et al., “Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting,” Circulation, vol. 115, no. 21, pp. 2745–2749, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. D. Dake, G. M. Ansel, M. R. Jaff et al., “Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month zilver PTX randomized study results,” Circulation: Cardiovascular Interventions, vol. 4, no. 5, pp. 495–504, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. B.-N. Nguyen, M. F. Conrad, J. M. Guest et al., “Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent,” Journal of Vascular Surgery, vol. 54, no. 4, pp. 1051.e1–1057.e1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Krankenberg, M. Schlüter, H. J. Steinkamp et al., “Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the Femoral Artery Stenting Trial (FAST),” Circulation, vol. 116, no. 3, pp. 285–292, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Dick, H. Wallner, S. Sabeti et al., “Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions,” Catheterization and Cardiovascular Interventions, vol. 74, no. 7, pp. 1090–1095, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. O. Schlager, P. Dick, S. Sabeti et al., “Long-segment SFA stenting—the dark sides: in-stent restenosis, clinical deterioration, and stent fractures,” Journal of Endovascular Therapy, vol. 12, no. 6, pp. 676–684, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Scheller, U. Speck, C. Abramjuk, U. Bernhardt, M. Böhm, and G. Nickenig, “Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis,” Circulation, vol. 110, no. 7, pp. 810–814, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Cassese, R. A. Byrne, I. Ott et al., “Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials,” Circulation: Cardiovascular Interventions, vol. 5, no. 4, pp. 582–589, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Tepe, S. Schmitmeier, and T. Zeller, “Drug-coated balloons in peripheral arterial disease,” EuroIntervention, vol. 7, supplement K, pp. K70–K76, 2011. View at Google Scholar
  16. S. H. Duda, M. Bosiers, J. Lammer et al., “Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial,” Journal of Endovascular Therapy, vol. 13, no. 6, pp. 701–710, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Lammer, M. Bosiers, T. Zeller et al., “First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease,” Journal of Vascular Surgery, vol. 54, no. 2, pp. 394–401, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Bosiers, P. Peeters, J. Tessarek, K. Deloose, and S. Strickler, “The Zilver PTX single arm study: 12-month results from the TASC C/D lesion subgroup,” Journal of Cardiovascular Surgery, vol. 54, no. 1, pp. 115–122, 2013. View at Google Scholar · View at Scopus
  19. M. D. Dake, G. M. Ansel, M. R. Jaff et al., “Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the zilver PTX randomized and single-arm clinical studies,” Journal of the American College of Cardiology, vol. 61, no. 24, pp. 2417–2427, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Zeller, M. D. Dake, G. Tepe et al., “Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents,” JACC: Cardiovascular Interventions, vol. 6, no. 3, pp. 274–281, 2013. View at Publisher · View at Google Scholar
  21. T. Jahnke, R. Andresen, S. Müller-Hülsbeck et al., “Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial,” Journal of Vascular and Interventional Radiology, vol. 14, no. 1, pp. 41–51, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Lammer, T. Zeller, K. A. Hausegger et al., “Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (viabahn endoprosthesis with propaten bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease),” Journal of the American College of Cardiology, vol. 62, no. 15, pp. 1320–1327, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. R. R. Saxon, A. Chervu, P. A. Jones et al., “Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (viabahn endoprosthesis with heparin bioactive surface in the treatment of superficial femoral artery obstructive disease) trial,” Journal of Vascular and Interventional Radiology, vol. 24, no. 2, pp. 165–173, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. P. J. Geraghty, M. W. Mewissen, M. R. Jaff, and G. M. Ansel, “Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease,” Journal of Vascular Surgery, vol. 58, no. 2, pp. 386.e4–395.e4, 2013. View at Publisher · View at Google Scholar · View at Scopus